Lotus Pharmaceutical Co. Ltd Financials

Market Capitalization TW$57.98 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	10.68
Forward PE	9.43
Price to Sales TTM	TW$3.03
Price to Book MRQ	TW$2.77
Enterprise to Revenue	3.43
Enterprise to EBITDA	8.38

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	28.59%
Operating Margin	36.25%
Return on Assets TTM	11.07%
Return on Equity TTM	28.50%

Income Statement

Revenue TTM	TW$19,115,866,112
Revenue per Share TTM	TW$72.94
Quarterly Revenue Growth	12.70%
Gross Profit TTM	TW$11,535,883,264
EBITDA	TW$8,673,518,000
Net Income to Common TTM	TW$5,464,645,120
Diluted EPS TTM	TW$20.74
Quarterly Earnings Growth YoY	38.50%

Balance Sheet

Total Cash MRQ	TW$5,604,915,200
Total Cash per Share MRQ	TW$21.12
Total Debt MRQ	TW$
Total Debt to Equity MRQ	58.49
Current Ratio MRQ	1.93
Book Value per Share MRQ	TW$79.90

Cash Flow

Operating Cash Flow TTM	TW$7,119,137,792
Levered Free Cash Flow TTM	TW$2,671,927,296

1795 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	265,349,812
Float Shares	162,179,152
Avg 10 Volume	851,860
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	38.14%
% Held by Institutions	10.85%

Stock Price Summary

Beta	-0.02
Fifty Two Week Low	TW$172.50
Fifty Two Week High	TW$315.00
Fifty Two Week Change	-39.50%
Day 50 MA	TW$225.23
Day 200 MA	TW$251.44

Dividends and Splits

Forward Annual Dividend Rate	TW$4.65
Forward Annual Dividend Yield	2.10%
Trailing Annual Dividend Rate	TW$5.73
Trailing Annual Dividend Yield	2.57%
Payout Ratio	22.42%
Dividend Date
Ex Dividend Date	2024-08-05
Last Split Factor
Last Split Date	2010-09-08